Schrodinger: A Computational Platform That Is Likely Becoming Obsolete (SDGR)

Biomolecule structure bubble cell advanced background. Nano biological chain. 3d render.

~UserGI15994093/iStock via Getty Images


Schrodinger (NASDAQ:SDGR) is a computational biology platform that uses a physics-informed algorithm, free energy perturbation (FEP), combined with machine learning to design drugs. In addition to licensing its code out to pharmaceutical companies, the company operates a partnership

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *